Success Metrics

Active Trials
6(67%)

Phase Distribution

Ph phase_4
1
11%
Ph phase_2
4
44%
Ph phase_1
1
11%
Ph early_phase_1
1
11%
Ph phase_3
2
22%

Phase Distribution

2

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

9

all time

Status Distribution
Active(9)

Detailed Status

Recruiting5
Not yet recruiting3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
6
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 11 (11.1%)
Phase 24 (44.4%)
Phase 32 (22.2%)
Phase 41 (11.1%)

Trials by Status

recruiting556%
active_not_recruiting111%
not_yet_recruiting333%

Recent Activity

6 active trials
Showing 5 of 9
recruitingphase_2

GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

NCT07221214
recruitingphase_4

Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis

NCT07401992
recruitingphase_3

Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)

NCT07295223
recruitingphase_3

Epicardial Cardiac Fat-CT (EPIC-CT)

NCT07297589
recruitingearly_phase_1

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

NCT06338553
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07221214Phase 2

GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

Recruiting
NCT07401992Phase 4

Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis

Recruiting
NCT07295223Phase 3

Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)

Recruiting
NCT07297589Phase 3

Epicardial Cardiac Fat-CT (EPIC-CT)

Recruiting
NCT06338553Early Phase 1

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Recruiting
NCT06827002Phase 1

Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults

Active Not Recruiting
NCT07200622Phase 2

Oral Semaglutide in Patients With Alzheimer's Disease

Not Yet Recruiting
NCT07179120Phase 2

Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health

Not Yet Recruiting
NCT07135245Phase 2

Improved Treatment and Monitoring of Alzheimer's Disease

Not Yet Recruiting

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9